ArticleAmerican journal of ophthalmology case reports2026
Cataract surgery with implantation of small aperture acrylic hydrophobic IOL to reduce photophobia in a patient affected by oculocutaneous albinism.
Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: IC-8™ intraocular lens (Bausch + Lomb, Bridgewater, USA) is a hydrophobic monofocal lens featuring an annular diaphragm design that may reduce photophobia-a common symptom in patients with oculocutaneous albinism (OCA). We report the implantation of the IC-8™ lens in an OCA patient undergoing cataract surgery to improve visual acuity and reduce photophobia. Observation: An 80-year-old female with OCA presented with progressive visual decline and severe photophobia. Corrected and uncorrected distance visual acuity (CDVA/UDVA) was 1.0 logMAR in both eyes; corrected near visual acuity (CNVA) was 0.60 logMAR in both eyes. Clinical findings included pendular nystagmus, extensive iris atrophy, foveal hypoplasia, and newly developed bilateral cortical cataracts. Best previously documented visual acuity was 0.50 logMAR in both eyes. Standing significant photophobia, bilateral phacoemulsification with IC-8™ IOL implantation was performed. Surgery and recovery were uneventful. Six months postoperatively, CDVA improved to 0.50 logMAR and UDVA to 0.70 logMAR in each eye; CNVA improved to 0.40 logMAR in each eye. Subjective reduction in photophobia was measured using 12-Item Utah Photophobia Symptom Impact Scale (UPSIS-12), score improving from 12 preoperatively to 2 postoperatively. Conclusions and importance: The IC-8™ intraocular lens may be considered as an off-label surgical option in OCA patients undergoing cataract surgery, offering not only visual rehabilitation but also photophobia consistent reduction
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.